Label-conscious consumers overlook ingredients in…
Americans are more ingredient-conscious than ever before — but not in all areas, according to new research.
A survey inspecting the mindsets of 2,000 Americans aged 30–54 reveals a growing cultural development: people are paying nearer consideration to what’s in the merchandise they buy usually, whether or not it’s pet food, groceries, skincare merchandise or dietary supplements.
Yet, in an age of label-reading and ingredient-driven decisions, the findings confirmed that aesthetic therapies, such as injectable frown line therapies, stay an space where familiarity often outweighs informed decision-making.
Americans are more ingredient-conscious than ever before — but not in all areas, according to new research. Vladimir Razgulyaev – stock.adobe.com
The survey, carried out by Talker Research on behalf of Revance, polled 2,000 U.S. adults aged 30–54 and discovered that 91% of respondents said they’re more ingredient-aware than ever before, yet fewer than half may title a single ingredient in their injectable frown line treatment.
According to the findings, this rise in ingredient awareness is being pushed by a want for better outcomes across a number of classes like skincare, dietary supplements, and hair care, with the bulk of respondents saying they research ingredients to guarantee a product works properly (61%).
The survey discovered that 91% of respondents said they’re more ingredient-aware than ever before. Revance/SWNS
Others cited advantages like managing allergic reactions (41%) and understanding product variations (36%).
Over half (51%) said their research before utilizing sure merchandise, therapies or ingredients had elevated considerably in the last 12 months.
“It’s encouraging to see consumers becoming more thoughtful about the products they use,” said a spokesperson for Revance. “They’re doing their homework, asking better questions and anticipating more data from manufacturers. But this research exhibits there’s still a hole when it comes to aesthetic therapies.
The majority of respondents said they research ingredients to guarantee a product works properly, while others cited advantages like managing allergic reactions and understanding product variations. Revance/SWNS
The findings confirmed that aesthetic therapies, such as injectable frown line therapies, stay an space where familiarity often outweighs informed decision-making. Revance/SWNS
AI usage could also be impacting this growth in product research, with 31% feeling it has already geared up them to make better product choices with less laborious research.
Despite having this technology at our fingertips, the data exhibits that ingredient curiosity hasn’t absolutely prolonged to aesthetic therapies.
The outcomes confirmed some important misconceptions, with 53% believing all injectable frown line therapies are “more or less the same” despite real variations in formulations.
The outcomes confirmed some important misconceptions, with 53% believing all injectable frown line therapies are “more or less the same” despite real variations in formulations. Revance/SWNS
The 2,000 respondents polled have been all at present receiving frown line therapies or meant to in the next six months.
Thirty-six % said they selected their current treatment because it was “the most obvious option,” while a comparable quantity (32%) have been unaware that various formulations even exist.
But that doesn’t imply Americans aren’t keen to change it up when it comes to their loyalty. Thirty-one % of those surveyed said they’d change an aesthetic product or treatment if it had an revolutionary formulation.
Despite having this technology at our fingertips, the data exhibits that ingredient curiosity hasn’t absolutely prolonged to aesthetic therapies. Pixel-Shot – stock.adobe.com
“Americans have become increasingly focused on what goes into the products they use, especially in categories like beauty and wellness,” the spokesperson added. “We’d like to see that same curiosity extend to frown line treatments so that people feel informed and confident about the different formulations available to them.”
Survey methodology:
Talker Research surveyed 2,000 people ages 30-54 who get neurotoxin therapies or need to in the next six months; the survey was commissioned by Revance and administered and carried out online by Talker Research between Aug. 5 and Aug. 12, 2025.
Stay in the loop with the latest trending topics! Visit our web site daily for the freshest lifestyle news and content, thoughtfully curated to inspire and inform you.
